Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 4 Comparisons of Drug Acquisition Costs of 5-Year NNT Among Antihypertensive Drug Classes

From: A cost-minimization analysis of diuretic-based antihypertensive therapy reducing cardiovascular events in older adults with isolated systolic hypertension

Drug Class

Commonly Prescribed

5-year Cost Per Patient

5-Year NNT

Total Cost

Incremental Cost

Cost Ratio

SHEP-based drug therapy

 

$456

15

$6,843

$0 (base)

1 (base)

Beta-Blocker

Atenolol

     
 

   25 mg daily

$1,255

15

$18,825

$11,982

2.75

 

   50 mg daily

$1,245

15

$18,675

$11,832

2.73

 

   100 mg daily

$1,792

15

$26,880

$20,037

3.93

ACE inhibitor

Enalapril

     
 

   5 mg daily

$2,031

15

$30,465

$23,622

4.45

 

   10 mg daily

$2,132

15

$31,980

$25,137

4.67

 

   20 mg daily

$3,034

15

$45,510

$38,667

6.65

Alpha-Blocker

Terazosin

     
 

   2 mg daily

$2,984

15

$44,760

$37,917

6.54

 

   5 mg daily

$2,984

15

$44,760

$37,917

6.54

 

   10 mg daily

$2,984

15

$44,760

$37,917

6.54

Calcium channel blocker

Nifedipine

     
 

   30 mg daily

$881

15

$13,215

$6,372

1.93

 

   60 mg daily

$1,762

15

$26,430

$19,587

3.86

 

   90 mg daily

$2,644

15

$39,660

$32,817

5.8